Skip to content

Implementation of a GDT Algorithm for Major Surgery Patients

Implementation and Effects of Pulse-contour-automated SVV/CI Guided Goal Directed Fluid Therapy Algorithm for the Routine Management of Major Abdominal Surgery Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02509910
Enrollment
300
Registered
2015-07-28
Start date
2013-07-31
Completion date
2015-07-31
Last updated
2015-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colectomy, Fluid Therapy, Pancreatectomy

Keywords

Major abdominal surgery, Goal directed therapy

Brief summary

This study examines the effect of an algorithm for GDT for patients undergoing major surgery under routine conditions.

Detailed description

Goal directed fluid management in major abdominal surgery has been shown to reduce perioperative complications. The approach aims to optimize the intravascular fluid volume by use of minimally invasive devices which calculate flow-directed variables such as stroke volume (SV) and stroke volume variation (SVV). The investigators aim to show the feasibility of routinely implementing such hemodynamic monitoring during major abdominal surgery, and to evaluate its effects in terms of perioperative fluid management and postoperative outcomes.

Interventions

None listed

Sponsors

Philipps University Marburg
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* pancreatic surgery * colorectal surgery

Exclusion criteria

* admission for revisional surgery

Design outcomes

Primary

MeasureTime frame
Length of stay in hospital90 days

Secondary

MeasureTime frame
intraoperative crystalloid volume1 day
intraoperative colloid volume1 day
Length of stay at ICU90 days
Total amount of complications per patient90 days
Insufficiance of bowel anastomosis90 days
acute renal failure90 days
ACS90 days
Sepsis90 days
Intraabd. Infection90 days
wound infection90 days
UTI90 days
Pneumonia90 days

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026